These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17482958)

  • 1. CYP19 TCT tri-nucleotide Del/Del genotype is a susceptibility marker for prostate cancer in a Taiwanese population.
    Huang YC; Chen M; Lin MW; Chung MY; Chang YH; Huang WJ; Wu TT; Hsu JM; Yang S; Chen YM
    Urology; 2007 May; 69(5):996-1000. PubMed ID: 17482958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.
    Healey CS; Dunning AM; Durocher F; Teare D; Pharoah PD; Luben RN; Easton DF; Ponder BA
    Carcinogenesis; 2000 Feb; 21(2):189-93. PubMed ID: 10657957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls.
    Ma X; Qi X; Chen C; Lin H; Xiong H; Li Y; Jiang J
    Breast Cancer Res Treat; 2010 Jul; 122(2):495-501. PubMed ID: 20052540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a (TTTA)n microsatellite and a TCT del/ins polymorphisms in the aromatase gene (CYP19) with hip fracture risk in Mexican postmenopausal women.
    Casas-Avila L; Valdés-Flores M; Miranda-Duarte A; Ponce de León-Suárez V; Castro-Hernández C; Rubio-Lightbourn J; Hidalgo-Bravo A
    Gynecol Endocrinol; 2015; 31(12):987-91. PubMed ID: 26426292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Yamanaka H
    Anticancer Res; 2003; 23(6D):4941-6. PubMed ID: 14981949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP19 (aromatase) haplotypes and endometrial cancer risk.
    Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
    Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
    Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
    Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.
    dos Santos RM; de Jesus CM; Trindade Filho JC; Trindade JC; de Camargo JL; Rainho CA; Rogatto SR
    DNA Cell Biol; 2008 Sep; 27(9):497-503. PubMed ID: 18491956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between gynecomastia and aromatase (CYP19) polymorphisms.
    Czajka-Oraniec I; Zgliczynski W; Kurylowicz A; Mikula M; Ostrowski J
    Eur J Endocrinol; 2008 May; 158(5):721-7. PubMed ID: 18426832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women.
    Kado N; Kitawaki J; Obayashi H; Ishihara H; Koshiba H; Kusuki I; Tsukamoto K; Hasegawa G; Nakamura N; Yoshikawa T; Honjo H
    Hum Reprod; 2002 Apr; 17(4):897-902. PubMed ID: 11925378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.
    Gennari L; Masi L; Merlotti D; Picariello L; Falchetti A; Tanini A; Mavilia C; Del Monte F; Gonnelli S; Lucani B; Gennari C; Brandi ML
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2803-10. PubMed ID: 15181061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians?
    Letonja M; Peterlin B; Bregar D; Petrovic D
    Folia Biol (Praha); 2005; 51(3):76-81. PubMed ID: 16045239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
    Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
    Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the association between the CYP19 Tetranucleotide (TTTA)n polymorphism and polycystic ovarian syndrome(PCOS) in Han Chinese women.
    Hao CF; Zhang N; Qu Q; Wang X; Gu HF; Chen ZJ
    Neuro Endocrinol Lett; 2010; 31(3):370-4. PubMed ID: 20588246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
    Van Pottelbergh I; Goemaere S; Kaufman JM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3075-81. PubMed ID: 12843146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals.
    Suspitsin EN; Grigoriev MY; Togo AV; Kuligina ES; Belogubova EV; Pozharisski KM; Chagunava OL; Sokolov EP; Theillet C; Berstein LM; Hanson KP; Imyanitov EN
    Eur J Cancer; 2002 Sep; 38(14):1911-6. PubMed ID: 12204674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
    Park K; Kim JH; Jeon HG; Byun SS; Lee E
    Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population.
    Xu P; Zhang XL; Xie GB; Zhang CW; Shen SM; Zhang XX; Cao YX; Wang WJ; Che YN; Xia YJ; Wu XK; Yi L; Gao Q; Wang Y
    Mol Biol Rep; 2013 Aug; 40(8):5041-7. PubMed ID: 23661022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.